Vasoplegia clinical trials at UCSF

1 research study open to eligible people

Vasoplegia means blood vessels are too relaxed, causing low blood pressure. UCSF is conducting trials to see if Angiotensin II helps in liver transplants. The focus is on the safety and effectiveness of this treatment.

Showing trials for

  • Angiotensin II in Liver Transplantation

    open to eligible people ages 18 years and up

    The purpose of this study is to determine the efficacy and safety of Angiotensin II as a second-line vasopressor (drug that raises the blood pressure) during liver transplantation.

    San Francisco, California

Our lead scientists for Vasoplegia research studies include .

Last updated: